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Slllnlmal-y 
Morbidity in humans infected with Schistosoma mansoni results primarily from the deposition 
of parasite eggs in portal areas where they induce a granulomatous response.  In mice infected 
with this helminth granuloma formation is a CD4 + T helper (Th) cell-dependent process that 
is associated with a strong Th2 cytokine response which appears to evolve through a Th0 phase. 
In this report, we asked whether endogenously synthesized or exogenously induced interferon 
(IFN)3' through its suppression of Th2 cell expansion exerts a regulatory role on egg pathology. 
Depletion of IFN-3, or natural killer cells resulted in a marked enhancement of granuloma formation 
around intravenously injected eggs and was associated with increased Th2 and decreased Thl 
and interleukin (IL)12 mRNA expression. Similar changes occurred when egg-injected mice were 
treated with neutralizing monoclonal antibodies specific for IL-12 indicating a role for this cytokine 
in the regulation of the granulomatous response. In contrast, treatment with exogenous rlL-12 
profoundly inhibited primary granuloma formation while increasing  IFN-% IL-2, IL-10,  and 
IL-12 pulmonary mRNA levels and suppressing IL-4, IL-5, IL-6, and IL-13 mRNA expression. 
Cytokine depletion studies indicated that the effects of IL-12 could be attributed primarily to 
increased  IFN-%  Importantly, IL-12  also inhibited secondary granuloma formation in mice 
presensitized with eggs demonstrating a role for the cytokine in reversing established Th2-type 
responses. Moreover, mice sensitized with eggs in combination with IL-12 to precommit them 
toward a Thl response developed only minimal granulomas upon subsequent egg challenge. The 
latter findings suggest that simultaneous vaccination with antigen plus IL-12 may provide a strategy 
for the prevention of schistosome egg pathology as well as other diseases stemming from Th2 
cytokine production. 
S 
chistosomiasis is a chronic helminthic disease that affects 
more than 200 million people worldwide (1). The mor- 
bidity in schistosome infections is primarily due to fibrosis 
resulting in large part from the granulomatous response to 
parasite eggs in tissues (2). In Schistosoma mansoni-infected 
mice, egg granuloma formation has been characterized  as a 
CD4 + T cell-dependent delayed-type hypersensitivity reac- 
tion (3, 4) and based on previous analyses of this process, 
should result from Thl-like (IFN-3'  and IL-2) cytokine re- 
sponses (5). Unexpectedly, egg deposition was found to as- 
sociate primarily with increases in Th2 cytokine (IL-4, IL-5, 
and IL-10) expression (6, 7). Two recent studies examined 
the kinetics of cytokine mRNA (8) and protein expression 
(9) after the injection of parasite eggs and concluded that 
the egg-specific Th2 response is preceded by a Th0 phase of 
cytokine expression. Moreover, cytokine-depletion studies in- 
dicated that both IL-2 and IL-4 are required for granuloma 
formation in naive animals and for the development of T cells 
expressing IL-4 and IL-5 mILNA (8). Neutralization of IL-2 
or IL-4, while suppressing granuloma formation, did not affect 
or slightly enhanced expression of IFN-'y and IL-2 mKNA, 
thereby confirming a predominant role for Th2 cells in granu- 
loma formation (8). 
If Th2 responses play a dominant role in granuloma for- 
mation,  then it  may be possible  to regulate schistosome 
pathology by the use of immunomodulators that suppress 
Th2 cytokine expression. In this regard, IFN-3' has been shown 
to have potent downregulatory effects on Th2 cell expansion 
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role in selectively promoting Thl cell differentiation (12, 13). 
It was recently demonstrated that a non-T, non-B cell, the 
NK cell, can provide a major source of this immunoregula- 
tory cytokine (14). In addition, IL-12, a newly characterized 
cytokine, produced primarily by macrophages and B cells 
(15-17),  has been shown to play an important role in the 
induction of IFN-3' synthesis by NK cells (18, 19) as well 
as activated T  cells (18) and appears to selectively stimulate 
Thl cell differentiation (20,  21). 
Several observations are consistent with a possible regula- 
tory role for IFN-3' in schistosome egg pathology. Thus, this 
cytokine is expressed during the early stages of liver granu- 
loma formation in infected mice (22, 23) and in the first few 
days of pulmonary granuloma formation after intravenous 
egg injection (8). Moreover, NK cells have been demonstrated 
within granulomas (24) and thus could provide a source of 
the initial IFN-3' response. Lastly, IFN-'y inhibits egg granu- 
loma formation in an in vitro model (25). 
The aim of this study was to directly assess the regulatory 
functions of NK cells, IFN-3', and IL-12 in granuloma for- 
mation in vivo. As described below, depletion of NK cells, 
IFN-3', or IL-12 increased primary granuloma size and Th2 
cytokine mRNA expression while decreasing Thl cytokine 
mRNA levels, indicating a major role for this pathway in 
endogenous regulation of the granulomatous response. More 
importantly, exogenous IL-12 was shown to cause a near com- 
plete inhibition of both primary and secondary granuloma 
formation while suppressing the egg-induced Th2 response. 
Finally, we demonstrate that IL-12 administered during pri- 
mary stimulation with eggs precommits the response in the 
Thl  direction  and  thus  protects  mice  from  subsequent 
pathology due to secondary exposure to eggs. Together, these 
results suggest that IL-12-induced immunomodulation may 
have major potential as a strategy for preventing egg-induced 
pathology in schistosomiasis. 
Materials and Methods 
Laboratory Hosts.  6-wk-old  female C3H/HeN and C57BL/6 
mice were purchased from the Division of Cancer Treatment, Na- 
tional Cancer Institute  (Frederick, MD). 
Antibody and Cytokine  Reagents.  A neutralizing mAb specific 
for murine IFN-3, (XMG 1.6) and a rat IgG control (GLl13) directed 
against Escherichia coli B-galactosidase  (kindly provided by Dr. John 
Abrams, DNAX, Palo Alto, CA) were purified by precipitation 
with ammonium sulfate from ascites. In some experiments, mice 
were injected intraperitoneally with 1 or 2 mg XMG1.6 anti- 
body/dose in 0.5 ml of saline at -1,  +3, and +6 d after the initial 
intravenous injection of S. mansoni eggs. For elimination of NK 
cells (14, 26), either a rabbit anti-asialo GM1 polyclonal serum 
(Wako Chemicals, Richmond, VA) or mAb PK136 directed against 
NKI.1 was utilized. Animals were treated with 1.2 mg anti-asialo 
GM1 on days -4 and  -1. Mice treated with mAb PK136 were 
given 1 mg on the same days. Control animals were injected with 
GLl13 or normal rabbit serum (Sigma Chemical Co., St. Louis, 
MO) on a similar regimen. The gamma globulin fraction of serum 
was obtained by 50% ammonium sulfate precipitation followed  by 
dialysis with PBS, pH 7.2. Animals depleted of 1I.,12 were treated 
on days -1 and  +3 with 0.5 mg each of mAbs C15-6.7.5 and 
C15-1.2.1 (kindly  provided  by M. Wysocka  and G. Trinchieri,  Wistar 
Institute, Philadelphia, PA). Mice depleted of Ibl0 were injected 
intraperitoneally with 2.5 mg each of mAbs SXC-1 and SXC-2 
on days -1,  +3,  +6, and  +10. Animals treated with rlL-12 (a 
gift from S. P. Wolf, Genetics  Institute Inc., Cambridge, MA) were 
injected intraperitoneally with 0.25/~g/day on days 0-3 and 6-7 
after intravenous injection of parasite eggs. 
Induction  of Pulmonary  Granulornas.  The  induction  of syn- 
chronous egg-induced granulomas was performed as described  pre- 
viously (27). Briefly,  S. mansoni eggs were extracted from the livers 
of infected mice (Biomedical Research Institute, Rockville, MD) 
and enriched for mature eggs (8). To induce primary granulomas, 
mice were injected intravenously  with 5,000 eggs. In some experi- 
ments, mice were sensitized by intraperitoneal injection of 5,000 
parasite eggs with a 1-wk regimen of  rib12 or saline. Animals  were 
killed 1-18 d after egg injection and the right lung placed in 1 
ml ofRNA STAT-60 (Tel-Test, Inc., Friendswood, TX) and frozen 
on dry ice in preparation for RNA extraction. 
Histopathology and Serology.  For measurement of granulomas, 
the left lung was inflated  with Bouin-HoUande  fixative  and processed 
routinely. The size of the pulmonary granulomas was determined 
in histological sections stained by Litt's (28) modification of the 
Dominici stain. The diameters of each reaction containing a single 
egg were measured with an ocular micrometer. Numbers of eo- 
sinophils and other cell types were evaluated  in the same sections. 
Isolation and Purification of mRNA.  RNase-free  plastic  and water 
were used throughout. The right lung was homogenized in I ml 
RNA STAT-60 using a tissue polytron (Omni International Inc., 
Waterbury, CT) and total RNA isolated as recommended by the 
manufacturer. The RNA was resuspended  in diethylpyrocarbonate- 
treated water  containing  1 mM  EDTA and quantitated  spec- 
trophotometrically. RNA gel electrophoresis was performed when 
necessary to confirm that RNA was intact and that the concentra- 
tion had been determined correctly. 
RT-PCR Detection of Cytokine mRNAs.  A reverse transcriptase- 
PCR procedure was performed to determine relative quantities of 
mRNA for II.-2, IL-4, IL-5, IL-6, Ibl0, IFN-% II.-12 (p35 and p40 
subunits), IL-13, and Hypoxanthine-guanine  phosphoribosyl  trans- 
ferase (HPRT) 1. A brief description of the procedure employed 
follows. Reverse transcription of I/zg of RNA was performed as 
previously  described (8). The final cDNA preparation was diluted 
1:8 and used in the PCR. The primers and probes for all genes 
except IL-13 (sequence kindly  provided by  Robert  Coffman, 
DNAX),  p40, and NKI.1 have been previously published (8, 29, 
30). Primers and probes for p40, IL-13,  and NKI.1 were as follows: 
1040 sense, CGTGCTCATGGCTGGTGCAAAG,  antisense, GAA- 
CAC~GCCCACTTGCTG, probe, GCTCAGGATCGCTATTAC; 
IL-13 sense, CTCCCTCTGACCCTTAAGGAG, antisense, GAA- 
GGGGCCGTGGCGAAACAG, probe, TCCAATTGCAATGC- 
CATCTAC; NKI.1  sense, CTACCTCGGTTTAAAGCCACC, 
antisense, GAAGCACAGCTCTCAGGAGTCAC, probe, GTT- 
TCTCAAGTTTCCAACACTTG. The PCR reaction was as pre- 
viously  described (8). PCR reaction conditions  were strictly defined 
for each cytokine primer pair such that a linear relationship be- 
tween input RNA and final  PCR product was obtained. Both posi- 
tive and negative controls were included in each assay to confirm 
that only cDNA PCR products were detected and that none of 
the reagents was contaminated with cDNA or previous PCR prod- 
ucts. The number of PCR cycles selected for each cytokine was 
t Abbreviation used in this paper: HPRT, Hypoxanthine-guanine  phosphori- 
bosyl transferase. 
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(28), p35 (30), p40 (33), I1.-13 (33), NKI.1 (30), and Iqpp,  T  (21). 
Analysis and Quantitation of  PCR Products.  After the appropriate 
number of PCIL cycles, the amplified DNA was analyzed by dec- 
trophoresis, Southern blotting, and hybridization with nonradio- 
active cytokine-specific probes as previously described (8). The che- 
miluminescent signals were quantified using a scanner (model 600 
ZS; Microtek, Torrance,  CA). The amount of PCR product was 
determined by comparison of signal density to that of  standard curves 
generated from simultaneously  amplified  step-wise  dilutions  of 
cDNA obtained from samples with high amounts (as determined 
from initial experiments) of specific cytokine mRNA. Fold increase 
was calculated  as the reciprocal of the equivalent dilution of con- 
trol cDNA and results were normalized for the relative quantity 
of total mRNA by comparison to HPRT when necessary. Mean 
fold changes and standard errors were calculated  from the signal 
densities obtained from four to eight animals analyzed at each time 
point. 
Statistics.  Statistical  significance  was determined by Student's 
t test and significance  was determined with p  values <0.05.  All 
experiments were repeated one or more times with similar results. 
Results 
Depletion of IFN-  3, Increases Th2-1ike  Cytokine Expression 
and Granuloma Formation.  To assess the role of IFN-T in pul- 
monary granuloma formation, C3H/HeN mice were injected 
intravenously with parasite eggs and IFN-~/neutralized with 
mAb XMG1.6. Mice were killed 1, 3, 6, and 14 d after injec- 
tion of eggs.  Neutralization of IFN-3' resulted in increased 
granuloma  size (p <0.05)  by day 14 which is routinely the 
peak time of granulomatous  inflammation  during primary 
responses (Fig.  1 A).  Analysis of lung cytokine mRNA  re- 
Figure  1.  Depletion  oflFN-"/or 
NK  cells increases pulmonary 
schistosome  egg granuloma forma- 
tion. C3H/HeN (A) or C57BL/6 
(B and C) mice were injected  intra- 
venously  with  5,000 eggs and 
treated with either control Abs, or 
neutralizing  mAbs to  IFN-'y  (1 
rag/dose XMG1.6) or depleted of 
NK cells by injection with  anti- 
asialo GM1  as  described in  Ma- 
terials  and  Methods.  Four 
animals/group were killed at  the 
times indicated and mean granu- 
loma volume +  SE (A and B) and 
NKI.1 mRNA levels  (C) measured 
in the lungs. (*) The depleted  group 
is  significantly different (p <.05) 
from the control by Student's t test. 
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and IL-10 mRNA at late time points, whereas levels of the 
Th2 cytokines IL-4, IL-5, IL-6, and IL-13 were elevated  at 
nearly all times (Fig.  2). 
NK  Cells  Suppress Granulomatous  Inflammation  and  Th2 
Cytokine  mRNA  Expression.  To investigate the contribu- 
tion of NK  cells  in  the primary granulomatous response 
and in Thl/Th2 subset selection, C3H/HeN animals were 
depleted  of NK  cells  by treatment  with  anti-asialo  GM1 
Abs. This procedure, similar to IFN-3, neutralization, signi- 
ficantly enhanced granuloma size by day 14 (Fig. 1 A). Anti- 
asialo GMl-treated mice also demonstrated reduced (10-fold) 
IFN-3, mRNA expression, an effect that was most pronounced 
at  early  time  points  (Fig.  2).  As  was  observed in  IFN- 
q-depleted mice, a significant increase in Th2 cytokine mRNA 
expression occurred at most time points. To confirm the effect 
of anti-asialo  GM1 on NK cells, egg-injected C57BL/6 mice 
were treated with the Ab in a second experiment and altera- 
tions in granuloma size (Fig.  1 B) correlated with decreased 
expression ofNKl.1 mRNA (Fig.  1 C). Treatment with the 
polyclonal serum again increased granuloma size (Fig.  1 B). 
As predicted (24), message for NKI.1 rapidly increased after 
35 
30" 
25" 
IFN-~,  IL-2  IL-10  IL-12 
injection of parasite eggs into control animals.  This eleva- 
tion in NKI.1 message was completely abrogated in animals 
treated with anti-asialo GMt (Fig.  1 C). In additional exper- 
iments, treatment with PK136, a mAh specific for NKI.1 + 
cells  also  significantly enhanced granuloma formation, al- 
though  the  changes  were less marked  than  in  the  asialo 
GMl-treated animals  (data not shown) as has been observed 
previously in other comparisons of these two reagents (31). 
Mice Injected with Parasite Eggs  Show Increased Expression 
oflL-I2p40  mRNA.  Since IL-12 plays a major role in the 
regulation of IFN-3, expression by NK and T cells, we exam- 
ined the induction of this cytokine during the early stages 
of granuloma formation. As shown in Fig. 2, a modest but 
highly significant increase in IL-12 p40 mRNA was detected 
after injection of eggs,  reaching a maximum by day 3 and 
returning to baseline levels by day 14.  The p35 subunit of 
IL-12 was expressed constitutively in the lungs of untreated 
animals and was slightly downregulated after injection of eggs 
(data not shown). It is interesting to note that depletion of 
NK cells  or IFN-3, completely blocked the increased  p40 
mRNA expression, suggesting a primary role for NK cell-de- 
rived IFN-y in inducing IL-12 expression in this model. 
Neutralization of Endogenous IL-12 during Pulmonary Granu- 
loma Formation Significantly  Increases Granuloma Size  While 
Suppressing Thl and Increasing Th2 Cytokine mRNA Levels.  To 
assess the role of endogenous IL-12 in primary granuloma 
formation, neutralizing antibodies  to IL-12 were administered 
to  mice injected with  eggs  as  described in  Materials and 
Methods. A  dramatic increase  (p <0.05) in granuloma size 
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Figure 2.  Depletion  of NK cells or IFN-y increases Th2 and decreases 
Thl cytokine  mRNA expression  in the lungs of mice injected  with para- 
site eggs. C3H/HeN mice  were injected  with 5,000  eggs  and treated  with 
neutralizing mAbs to IFN-3, (1 mg/dose,  filled triangles) or depleted of 
NK cells with anti-asialo GM1 Abs (1.2 mg/dose,  filled circles) as above. 
mRNA levels  are expressed  relative  to levels  in uninjected  controls  at day 0 
(given an arbitrary value of 1) and are expressed as the mean _+  SE of 
determinations on lungs from four individual  mice. (*) The treated  group 
is significantly  different from the control group at that time point. 
Figure 3.  Neutralization  of  endogenous  IL-12  increases  whereas adminis- 
tration of exogenous  rlL-12 decreases  primary  egg granuloma formation. 
In two separate  experiments,  C57BL/6  mice  were  injected  with 5,000  eggs 
and either depleted of II.-12 (A) or given recombinant II.-12 (B) during 
the first week of granuloma formation. In A, mice were injected in- 
traperitoneally  with 1 mg control mAb GLl13 (filled circles)  or with 0.5 
mg of each anti-IL-12 mAb (C15 6.7.5 and C15 1.2.1, open squares) on 
days -1, and  + 3. In B, mice were treated with saline (filled circles) or 
0.25/zg/day  of  rlL-12 (open  triangles)  during  the first  week  of  primary  granu- 
loma formation as described in Materials and Methods. Four to five 
mice/group were killed at each time point and granuloma volumes de- 
termined. 
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3 A). The pattern ofcytokine mRNA expression was similar 
to that  seen in mice depleted of IFN-3' (Figs.  2 and 4 A). 
There was no effect on the early Thl  response (days  1-6). 
However, both IFN-3' (days 10-14) and IL-2 (day 10) mRNA 
expression fell near or below baseline levels  suggesting an 
important role for IL-12 in stimulating late Thl-like cytokine 
responses.  By contrast, expression of the Th2 cytokines IL-4, 
IL-5, IL-6, and IL-13 was significantly elevated at several time 
points.  It is interesting to note that  as described above,  ex- 
pression of IL-10 did not follow the Th2 pattern but rather 
closely resembled the pattern of expression exhibited by the 
Thl cytokines, with depressed expression by days 10 and 14 
in animals in which IL-12 was neutralized.  IL-12 p35 or p40 
mRNA expression was not significantly affected by the deple- 
tion of endogenously expressed IL-12. 
Recombinant IL-12 Markedly Inhibits Primary Granuloma For- 
mation  While  Increasing Thl  and Decreasing Th2  Cytokine 
mRNA Levels.  The results from depleting IL-12 suggested 
that IL-12 primarily acts during the growth stages of granu- 
loma formation,  presumably by influencing  the expansion 
of NK cells or the development of Thl and/or CD8 + cells 
expressing IFN-'y.  We therefore  studied the effects of ad- 
ministering rlL-12 during the first week of granuloma for- 
mation to determine whether it would suppress egg-induced 
Th2 responses and thus inhibit the granulomatous response. 
The results revealed a dramatic reduction in granuloma size 
at all time points  (Fig.  3 B). Examination  of the cytokine 
mRNA responses in the lungs of these mice revealed pro- 
nounced increases in the Thl cytokines at nearly all time points 
(Fig. 4 B). IFN-3, mRNA levels were elevated by day 3 whereas 
IL-2 mRNA increased by day 6.  Both mRNAs remained 
devated through day 14. Exogenous rlL-12 also dramatically 
enhanced IL-12 p40 mILNA expression. Consistent with the 
results from the anti-IL-12 experiment (Fig. 4 A), IL-12 ap- 
peared to stimulate expression of IL-10. In contrast, mRNA 
levels for the other Th2 cytokines were almost completely 
suppressed in rIL-12-treated  animals.  A more than  10-fold 
reduction in IL-4 mRNA levels was observed by day 6, whereas 
IL-5, IL-6, and IL-13 were suppressed at nearly all time points, 
falling below constitutive levels. 
Neutralization of lFN-y but not IL-IO Dramatically Reverses 
the Suppressed Granuloma Formation and Th2 Cytokine mRNA 
Expression Induced by IL-12.  Together, the data described above 
suggest a major role for IL-12 and IFN-'y in limiting granu- 
lomatous inflammation, presumably by blocking Th2 cell ex- 
pansion and cytokine expression.  However, it was possible 
that the increased IL-10 levels in IL-12-treated mice might 
be responsible for the depressed granuloma  size,  given the 
known inhibitory effects of the former cytokine on inflam- 
matory gene expression (32). To distinguish between these 
mechanisms,  mice were treated with or without rIL-12 in 
combination with neutralizing mAbs to IFN-3, or IL-10. As 
expected,  mice  treated  with  rlL-12  displayed  suppressed, 
whereas animals given anti-IFN-3, displayed increased gran- 
ulomatous reactions (Fig. 5 A). Neutralization of IL-10 had 
only a small effect on granuloma  size, increasing  the mean 
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Figure 4.  Effect  of neutralization of endogenous 1I.-12 or addition of 
rlb12 on cytokine  mKNA expression in the lungs of egg-injected mice. 
Mice were treated as described in Fig. 3 except that the right lung was 
analyzed by KT-PCR  for cytokine  gene expression. (A) Egg-injected  mice 
were treated with a control mAb (GLl13,filled  circles)  or with neutralizing 
mAbs to IL-12  (open  squares).  For Ib12 mRNA expression, the p40 mRNA 
subunit is represented as filled circles (control) and open squares (anti-Ib 
12) whereas the p35 subunit is represented  by the filled (control) and open 
(anti-lb12) triangles. (B) Egg-injected  mice were treated with saline (filled 
circles) or with rib12 (open triangles). For Ib12 mKNA expression, the 
p40 mRNA is represented  by fined  circles (CONTROL) or open triangles 
(alL12) and the p35 subunit as fiUed  (CONTROL)  and open (riLl2) squares. 
(*) Denotes a significant difference  (p <.05) between  the two groups. There 
was a high constitutive level of p35 mKNA in all control animals that 
was gradually decreased (3-10-fold) after injection of eggs. 
volume by ",,10-15%.  Mice treated with rlL-12  plus neu- 
tralizing  mAbs to IFN-3, developed granulomas  similar to 
those seen in mice treated with anti-IFN-3~  alone.  In con- 
trast, mice treated with rlL-12 plus neutralizing abs to IL-10 
developed granulomas similar to those found in animals treated 
with IL-12 alone.  These data suggest that  the  suppressive 
effects of IL-12 are primarily mediated through  IFN-3' se- 
cretion. 
Analysis of cytokine expression in rlL-12 plus anti-IFN- 
3,-treated mice revealed  several interesting observations. As 
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Figure  5.  Neutralization  of IFN-'~ but not Ibl0 reverses the suppres- 
sion of granuloma  formation  and Th2 cytokine  expression  by rlL-12  during 
primary granuloma  formation.  C57BL/6  mice  were injected  intravenously 
with eggs  and treated  with a control  mAb (GLl13) and saline, rlL-12 (0.25 
#g/dose), anti-IFN-'y mAb  (2  mg/dose), anti-IL-10 mAbs (2.5 mg 
each/dose), or with a combination  of 1I.-12 plus anti-IFN-3,  or II.-12 plus 
anti-IL-lO. A total of eight mice  per group was killed on day 14, the time 
of peak granuloma  formation  and granuloma  volumes  (/1) and cytokine 
mRNA expression (B) assessed in the lungs of each animal. The values 
shown are the means +_  SE. 
expected, mice treated with rlL-12 displayed suppressed IL-4, 
IL-5, IL-6, and IL-13 mRNA levels whereas IFN-% IL-2, 
IL-IO, and IL-12 were slightly enhanced (Fig. 5 B). In addi- 
tion, as seen in Fig. 2, neutralization of IFN-y resulted in 
depressed  IFN-% IL-2, IL-10, and IL-12 mRNA, whereas 
levels of IL-4, IL-5, IL-6, and IL-13 were either unaffected 
or slightly enhanced. Animals depleted of IFN-3~ and simul- 
taneously treated with rlL-12 showed enhanced rather than 
suppressed  IFN-% IL-2, or IL-IO mRNA expression,  sug- 
gesting that IL-12 may have a direct effect on the induction 
of these cytokines. Moreover, the same mice displayed restored 
IL-4 and IL-13  mR.NA expression,  approaching the levels 
seen in control and IFN-'y-depleted animals.  Nevertheless, 
only a modest reversal of the IL-5 mRNA suppression  was 
observed. It is interesting to note that IL-12 p40 mRNA ap- 
peared to be largely dependent upon IFN-3' for its induction 
as evidenced by its reduced expression in rlL-12 injected animals 
given anti-IFN-3/. 
rlL-12 Blocks the Accumulation of  Eosinophils in Granutomas. 
Histological examination of granulomas indicated that eo- 
sinophils were almost completely absent from the small le- 
sions found in rlL-12-treated animals (Fig. 6). Not surpris- 
ingly, mice treated with neutralizing mAbs to IFN-'y displayed 
dramatically increased numbers of eosinophils, reaching nearly 
50% of the total granuloma cell population, which correlated 
with increased mRNA levels of IL-5, a cytokine important 
in  the differentiation of eosinophils (33).  Although mice 
treated with rlL-12 plus anti-IFN-3, mAb displayed slightly 
increased numbers (12%) of eosinophils, their numbers did 
not approach the levels seen in IFN-y-depleted animals (50%) 
or controls (22%). Moreover,  these mice failed to show in- 
creased IL-5 mRNA levels (Fig.  5 B). 
rlL-12 Suppresses Granuloma Formation and Egg-induced Th2 
Responses in Sensitized Mice.  To determine whether IL-12 
would reverse established  Th2 cell responses  and suppress 
granuloma formation in a secondary response, mice were sen- 
sitized intraperitoneaUy with eggs and challenged 1 mo later 
with eggs together with rlL-12. In sensitized controls, there 
was a vigorous granulomatous response that was on average 
six to eight times greater than that seen in unsensitized animals 
(Fig. 7 A). Sensitized mice treated for 1 wk with rlL-12 after 
intravenous challenge of eggs showed a greater than fourfold 
reduction in granulomatous inflammation. Analysis of cyto- 
kine mRNA expression again demonstrated a significant in- 
crease in IFN-T, IL-2, and IL-10 mRNA expression at nearly 
all time points whereas mRNA levels for the Th2 cytokines 
IL-4, IL-5, and IL-13, although not altered at early time points 
(days 3-6), were slightly but significantly suppressed  (two- 
to fourfold) from days 10 through 14 (Fig.  7 B).  It is in- 
teresting to note that sensitized controls, but not IL-12-treated 
mice, displayed depressed IL-12 p40 and p35 mRNA expres- 
sion at all time points. 
IL-12 Administered during Egg Sensitization Precommits the 
Cytokine Response in the Thl Direction and Effectively Blocks 
Secondary  Granulomatous  Inflammation.  Since  our initial studies 
indicated that we could ablate Th2-1ike cytokine expression 
and suppress granuloma formation by early treatment with 
rlL-12 (Figs. 3 B and 4 B), we asked whether this approach 
could be used to develop a vaccine that would immunomodu- 
late subsequent egg pathology. For these studies, mice were 
50. 
￿9  t-  40  eL 
O  30  Z 
.I 
10 
0 
(:I~NI'I:OL  IL-12  IL-12  Ant I-IFN--~ 
Anti-IFN-y 
Figure 6.  Ib12  suppresses granuloma  eosinophil  numbers. Granulomas 
in the mice described  in Fig. 5 were analyzed  for eosinophil  numbers that 
were recorded as the mean (+_ SE) percent of cells present. 
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Figure  7.  Treatment  of mice with rlL-12 suppresses secondary  egg granu- 
loma formation while significantly increasing Thl and decreasing Th2 
cytokine  mR.NA  expression. C57BL/6  mice were sensitized by  in- 
traperitoneal injection of 5,000 eggs and 4 wk later challenged intrave- 
nously with 5,000 eggs. Different animal groups were treated with saline 
(filled triangles) or rlbl2 (0.25/~g/dose, open triangles) after challenge. Four 
mice per group were killed and granuloma volumes (A) and cytokine 
mRNA expression analyzed by RT-PCIL  (B). mRNA for p35 in the con- 
trol and rlL-12-treated  animals  is indicated by filled and open squares, respec- 
tively, and p40 by triangles. 
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Figure  8.  Sensitization of mice with parasite eggs plus IL-12  prevents 
secondary granuloma formation, is associated  with increased IL-12  and Thl 
cytokine expression, and dramatically  decreased  Th2 cytokine mRNA levels. 
C57BL/6 mice were sensitized by intraperitoneal injection of 5,000 eggs 
with (open triangles) or without (filled triangles) IL-12 (0.25 /*g/dose). 4 
wk after the last injection of IL-12, mice were challenged intravenously 
with 5,000 parasite eggs in the absence of additional exogenous cytokine 
and four animals per group killed for histological examination (.4) and 
RT-PCR analysis (B) of cytokines at the times indicated. The different 
cytokines are indicated with the same symbols used in Fig. 7. 
sensitized as described above except that one group received 
rIL-12 during the first week of sensitization.  1 mo after the 
last rlL-12 injection, the mice were challenged intravenously 
with eggs. As shown in Fig. 8 A, mice sensitized in the pres- 
ence of rIL-12, were almost completely protected from the 
secondary granulomatous response. Only a small accumula- 
tion  of ceils around  eggs was observed which  was  almost 
completely eliminated by day 14. The mRNA response indi- 
cated a strong anamnestic IFN-'/response and suppressed Th2 
cytokine expression in egg plus IL-12-sensitized mice (Fig. 
8 B). It is interesting to note that IL-12 p40 mRNA  expres- 
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sion was dramatically increased only in mice previously sen- 
sitized with  IL-12,  indicating  a  potential role for IL-12 in 
controlling  Thl/Th2  cytokine patterns  in these mice.  The 
p35 chain was again constitutively  expressed at high levels 
in untreated mice and was downregulated from 2- to 10-fold 
in both groups after the injection of eggs, although a significant 
level of p35 mKNA was still detected even at these later times. 
Mice injected with IL-12 alone failed to display upon subse- 
quent egg challenge the alterations in granuloma formation 
and cytokine expression observed in animals presensitized with 
eggs plus  IL-12 (data not  shown). Discussion 
By demonstrating that granuloma formation can be en- 
hanced or inhibited as a consequence of IFN-y regulation, 
the data presented in this study support the concept that Th2 
responses play a central role in egg-induced pathology. The 
latter hypothesis was based on the observation of enhanced 
Th2 cytokine synthesis induced during the formation of granu- 
lomas in infected mice (6, 7, 22) or in animals injected with 
schistosome eggs (8,  9,  34)  and on the inhibition of egg 
pathology caused by in vivo depletion of either IL-4 or IL-2 
(8), two cytokines required for the generation of Th2 responses 
in vitro (10, 35-37). As demonstrated here, manipulations 
involving IFN-3' or IL-12 in altering the granulomatous re- 
sponse also modified the expression of Th2 cytokines and in 
particular IL-4, a mediator previously implicated in the patho- 
genesis of egg lesions (6-8, 23, 34, 38-40). Effects on three 
other Th2 cytokines, IL-5, IL-6, and IL-13 were also noted. 
IL-5, while important in the recruitment of eosinophils, does 
not play a significant role in controlling the size of the le- 
sions (33). Similarly, we have been unable to inhibit granu- 
loma formation by in vivo depletion of IL-6 or by blocking 
the IL-6 receptor (our unpublished observations). In this study, 
IL-13, which has both structural and functional homology 
to IL-4 (41-44) was markedly induced by egg injection. The 
contribution of IL-13 to egg pathology has not been assessed 
and it is conceivable  that it, as well other uncharacterized 
Th2 products, may participate directly in the formation of 
granulomatous lesions. 
Previous reports suggested that IFN-3' has a regulatory role 
in granuloma formation in vitro (25) and in vivo (34, 45). 
In this study, we demonstrated that parasite eggs induce a 
rapid IFN-'y response that appears to interfere with the de- 
velopment of IL-4-producing Th2 cells, thus resulting in re- 
duced granuloma formation. Our data argue that NK cells 
are a likely source of the early IFN-'y since animals depleted 
of these cells  demonstrate a  marked reduction in  IFN-3, 
mRNA as well as an increase in granuloma size. As was ob- 
served in IFN-q'-depleted animals, the increase in granuloma 
size was associated with an increase in Th2 cytokine mRNA 
expression. Together these observations suggest that the early 
endogenous production of IFN-3' by NK cells through its 
regulation of T cell responses is a critical factor influencing 
granulomatous inflammation. Moreover, they support previous 
studies in mice infected with Leishmania major (14) indicating 
that the NK cell-IFN-3, pathway is a major determinant of 
Th cell subset selection. 
IL-12 has potent IFN-y stimulating activities on NK cells 
as well as on CD4 + and CD8 + T lymphocytes (18, 46, 47). 
In addition, it has been demonstrated in vitro to play a major 
role in directing the differentiation of Thl effector CD4 + 
cells (20,  21, 48, 49).  Biologically active IL-12  (50,  51) is 
a heterodimer, consisting of a constitutively expressed L chain 
(p35) and a H  chain (p40) that is induced in macrophages 
and several other cell types by a number of stimuli (15, 17). 
After primary injection of eggs, IL-12 p40 mRNA was in- 
duced rapidly in the lungs (Fig. 2). It is interesting to note 
that this induction was completely  blocked in animals depleted 
of IFN-'y or NK cells, suggesting an essential role for NK 
cell-derived IFN-3' in regulating IL-12 mRNA expression. 
The latter hypothesis is consistent with the known upregula- 
tory effects of exogenous IFN-'~  on IL-12 gene expression 
in vitro (17). Moreover, depletion of endogenous IL-12 resulted 
in an enhanced granulomatous response that was associated 
with an increase in Th2 cytokine mRNA levels similar to 
that observed in IFN-'y or NK cell-depleted mice. 
The above observations suggest the following mechanism 
for endogenous regulation of Th activity in primary granu- 
loma formation. Immediately after egg injection there is a 
rapid IL-12-independent NK cell-mediated IFN-3~ response. 
The induced IFN-3~ triggers IL-12 expression (presumably 
from macrophages) and together, IFN-y and IL-12 direct Thl 
cell expansion and cytokine expression while dampening the 
evolving Th2 response. IL-12 p40 mRNA expression itself 
is not significantly affected by depletion of IL-12, suggesting 
that it is primarily dependent upon the secretion of IFN-y 
by NK cells. Therefore, in this model, endogenous IL-12 does 
not appear to significantly affect the early NK cell response, 
but rather plays a more important role at later  times by 
directing the development of T cells expressing IFN-% The 
later conclusion is supported by the failure of anti-IL-12 mAb 
treatment to affect the early IFN-3, mRNA response medi- 
ated by NK cells (Fig.  4 A). 
Our results indicate that IFN-'y, IL-12, and NK cells are 
important immunomodulators of primary granulomatous 
inflammation in the lung. Therefore, we hypothesized that 
it should be possible to stimulate IFN-y expression and thus 
simultaneously inhibit granuloma formation by treatment with 
exogenous rlL-12.  Animals injected with rlL-12 had sig- 
nificantly smaller granulomas, and this change correlated with 
an almost complete suppression of Th2-like mRNA responses 
(Fig. 4 B). It is interesting to note that expression of IL-10 
was elevated in IL-12-treated animals,  suggesting that IL- 
l0, a potent downregulatory cytokine (32), could also con- 
tribute to the suppressed granulomatous response. However, 
depletion of IFN-3,, but not IL-10 restored Th2 mRNA re- 
sponses in IL-12-treated mice, arguing that the major sup- 
pressive effects of IL-12 on granuloma formation and Th2 
cytokine expression were mediated through IFN-3'. Neverthe- 
less, mice treated with IL-12 and depleted with anti-IFN-3' 
mAb continued to show elevated IFN-3,,  IL-2,  and IL-10 
mRNA levels, suggesting that in contrast to its IFN-q,-de- 
pendent effect on Th2 responses,  IL-12 directly stimulates 
Thl cytokine and IL-10 expression.  A direct role for IL-12 
in Thl cell differentiation has been hypothesized from in vitro 
studies using TCR transgenic CD4 + T cells (20, 21). Our 
present findings strongly support the existence of these mech- 
anisms in vivo. 
As indicated above, treatment with IL-12 caused a marked 
increase in IL-10 mRNA expression  in the lungs of egg- 
injected mice.  Since IL-10 is usually categorized as a Th2 
cytokine (52),  this finding was somewhat unexpected. In- 
deed, in an early series of experiments, IL-12 was found to 
suppress all soluble egg antigen induced recall responses, in- 
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really injected with schistosome  eggs (Oswald, I. P., P. Caspar, 
D. Jankovic, T. A. Wynn, E. J. Pearce, and A. Sher, manu- 
script in preparation).  This discrepancy probably  reflects a 
difference in the source of IL-IO in the two experimental sit- 
uations, T cells providing most of the cytokine in the recall 
experiments and macrophages supplying most of the IL-IO 
expressed in tissues. Regardless, it is unlikely that IL-12-in- 
duced IL-10 plays a role in the suppression of granuloma for- 
mation since anti-IL-10 treatment failed to reverse the reduc- 
tion in egg granuloma size induced by exogenous  IL-12 (Fig. 5). 
Eosinophils were almost completely absent from granu- 
lomas of animals treated with rlL-12. This observation cor- 
related  directly with  the decreased expression  of IL-5,  a 
cytokine that controls the differentiation of eosinophils (33). 
By contrast, animals depleted of IFN-3, (Fig. 6) or IL-12 (data 
not shown) displayed increased eosinophils in the lesions as 
well as elevated IL-5 mRNA levels (Figs. 2, 4 A, and 5 B). 
It is interesting to note, however, that the large granulomas 
in animals treated with IL-12 and anti-IFN-~/mAb contained 
few eosinophils (Fig. 6) and that IL-5 mRNA expression (Fig. 
5 B) remained low, suggesting that IL-12 may effect IL-5 
production and/or the differentiation and recruitment of eo- 
sinophils directly. Alternatively,  neutralization of IFN-% while 
sufficient to affect granuloma size, may have been insufficient 
to effect IL-5 and eosinophil development.  Studies on the 
effects of IL-12 on eosinophils  in nematode-infected  mice 
yielded similar findings (53). 
In addition to effecting  primary granuloma formation, IL-12 
profoundly inhibited the vigorous anamnestic granulomatous 
response in animals presensitized with eggs, and this sup- 
pression again correlated with a shift in Thl/Th2 cytokine 
mRNA expression (Fig. 7). The latter observations are of 
basic interest because they indicate that IL-12 can alter estab- 
lished Th2 responses. In the granuloma model the mecha- 
nism of this reversal is unclear. One possibility is that IL-12 
alters cytokine expression of Th2 cells in vivo causing them 
to shift to a Thl- or Th0-1ike pattern. This explanation is 
consistent with recent data showing that IL-12 can induce 
IFN-3' production in human Th2 cell lines (48) as well as 
clones (54). A second and more likely alternative is that in 
vivo IL-12 treatment drives the differentiation of the remaining 
egg-specific Th0 lymphocytes  in sensitized animals into Thl 
cells. Since in our experiments  the egg challenge was per- 
formed in a different site than the sensitization, it is also pos- 
sible that IL-12 injection results in the preferential recruit- 
ment of  Thl or Th0 cells from the peritoneum into the lungs. 
The above considerations are important since they may im- 
pact on the feasibility of using IL-12 therapeutically to sup- 
press granulomatous responses or allergic disorders (55, 56) 
in which Th2-like  responses dominate. 
The ability of IL-12 to suppress  both primary and secondary 
egg-induced Th2 responses suggested the possibility of pro- 
phylactically  immunizing mice against granulomatous inflam- 
mation by sensitizing them to egg antigens in the presence 
of exogenous IL-12. This resulted in nearly complete inhibi- 
tion of granuloma formation after challenge with eggs in 
the absence of additional  IL-12. As predicted,  pulmonary 
cytokine responses showed a reversal in Th expression pat- 
tern similar to that observed in animals treated with IL-12 
during primary egg injection. These results suggest that when 
given during priming, IL-12 effectively  switches the Th pheno- 
type of the subsequent memory  population, thereby altering 
the cytokine response during secondary antigenic stimula- 
tion.  Similar findings  have recently been obtained  in the 
L. major mouse model (26). Together, the data from both 
parasite experimental models suggest  that IL-12 may have 
important use as an immunomodulatory  agent during vacci- 
nation, altering both the quality and quantity of protective 
cell-mediated responses. Indeed, it is tempting to speculate 
that the action of certain bacterial adjuvants such as Bacillus 
Calmette-Gu~rin  may relate to their ability to induce IL-12 
during immunization. 
In the case of schistosomiasis, administration of egg an- 
tigens plus IL-12 could potentially  be used as an "anti-pa- 
thology" vaccine for preventing granulomatous disease (57). 
Studies are now in progress to determine whether IL-12 can 
reverse granuloma formation during natural infection and 
whether combined egg antigen-IL-12 vaccination can lead 
to a lasting protection against egg-induced tissues responses, 
fibrosis, and morbidity. If successful, this approach might 
lead to a method for controlling schistosomal disease that 
does not depend on interruption of infection. 
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